Inmune Bio (INMB) Total Liabilities (2017 - 2025)
Historic Total Liabilities for Inmune Bio (INMB) over the last 9 years, with Q3 2025 value amounting to $8.0 million.
- Inmune Bio's Total Liabilities fell 4343.23% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year decrease of 4343.23%. This contributed to the annual value of $7.5 million for FY2024, which is 6042.31% down from last year.
- Inmune Bio's Total Liabilities amounted to $8.0 million in Q3 2025, which was down 4343.23% from $8.8 million recorded in Q2 2025.
- In the past 5 years, Inmune Bio's Total Liabilities registered a high of $21.7 million during Q4 2022, and its lowest value of $2.3 million during Q1 2021.
- In the last 5 years, Inmune Bio's Total Liabilities had a median value of $17.9 million in 2022 and averaged $15.3 million.
- Per our database at Business Quant, Inmune Bio's Total Liabilities skyrocketed by 118181.51% in 2021 and then tumbled by 6042.31% in 2024.
- Quarter analysis of 5 years shows Inmune Bio's Total Liabilities stood at $19.7 million in 2021, then rose by 9.99% to $21.7 million in 2022, then fell by 13.04% to $18.9 million in 2023, then crashed by 60.42% to $7.5 million in 2024, then increased by 6.9% to $8.0 million in 2025.
- Its last three reported values are $8.0 million in Q3 2025, $8.8 million for Q2 2025, and $8.1 million during Q1 2025.